Do you want to buy antibiotics online without prescription? http://buyantibiotics24h.com/ - This is pharmacy online for you!

Microsoft word - cv still.docx

Sesso F | Data di nascita 01/08/1971 | Nazionalità italiana Docente di Patologia Clinica presso il Corso di Laurea del e Professioni Sanitarie in Igiene Dentale, l’Università di Docente presso i corsi di aggiornamento professionale organizzato dal ’ Assiprofar-Federfarma (“Il farmacista e Responsabile tecnico Mineralometria Ossea Computerizzata (MOC) presso studio ScudoSanitas Nutrizionista presso studio lo studio medico ScudoSanitas di Roma, presso la parafarmacia Healthy Center di Campagnano e collaboratrice presso lo studio medico dietologico del Prof. Migliaccio Diploma di Maturità Scientifica conseguito presso il liceo statale "Plinio Seniore" di Roma Laurea Magistrale in Scienze Biologiche, indirizzo Fisiopatologico, conseguita presso l'Università degli Studi di Roma "La Sapienza" con la votazione di 110/110 e lode Abilitazione al a professione di Biologa Dottorato di Ricerca in Fisiopatologia e Clinica del ’Apparato Scheletrico, Università di Roma “La Sapienza” Master in Biotecnologie presso l’Università degli Studi di Urbino Master in “Prevenzione e Assistenza a Obesità, Soprappeso e Disturbi del comportamento alimentare” presso l’Università di Roma “La Sapienza” ▪ possiedo buone competenze comunicative acquisite durante la mia esperienza di professore ▪ Sistema operativo Windows e Mac ▪ Programma di uso generale (Word, Excel, Power Point, Access) ▪ Altri programma fondamentali per la propria area professionale ▪ Utilizzo di Internet Unione europea, 2002-2012 | http://europass.cedefop.europa.eu ABNI Associazione Biologi Nutrizionisti Italiani - SIMEL società italiana medicina di laboratorio - SIOMMMS società italiana del ’Osteoporosi del Metabolismo Minerale e del e Malattie del o Scheletro ▪ Brama M, Politi L, Santini P, Migliaccio S, Scandurra R. Cadmium-induced apoptosis and necrosis in human osteoblasts: role of caspases and mitogen-
activated protein kinases pathways. J Endocrinol Invest. 2012 Feb;35(2):198-208. Epub 2011 Jun 218 ▪ Resmini G, Migliaccio S, Dal e Carbonare L, Sala U, Brama M, Fornari R, Maggi S, Siviero P, Malavolta N, Iolascon G: Differential characteristics of bone
quality and bone turnover biochemical markers in patients with hip fragility fractures and hip osteoarthritis: results of a clinical pilot study. Aging Clin Exp Res. 2011 Apr;23(2):99-105. ▪ Aversa A, Caprio M, Antelmi A, Armani A, Brama M, Greco EA, Francomano D, Calanchini M, Spera G, Luigi LD, Rosano GM, Lenzi A, Migliaccio S, Fabbri
A:Exposure to Phosphodiesterase Type 5 Inhibitors Stimulates Aromatase Expression in Human Adipocytes in vitro. J Sex Med. 2010 Dec 22. doi: 10.1111/j.1743-6109.2010.02152.
▪ Greco EA, Fornari R, Rossi F, Santiemma V, Prossomariti G, Annoscia C, Aversa A, Brama M, Marini M, Donini LM, Spera G, Lenzi A, Lubrano C, Migliaccio
S: Is obesity protective for osteoporosis? Evaluation of bone mineral density in individuals with high body mass index. Int J Clin Pract. 2010 May;64(6):817-20.
▪ Migliaccio S, Brama M, Malavolta N:Management of glucocorticoids-induced osteoporosis: role of teriparatide.
Ther Clin Risk Manag. 2009 Apr;5(2):305-10
▪ Rossi FM, Castel i A, Bianco MJ, Bertone C, Brama M, Santiemma V: Ghrelin inhibits contraction and proliferation of human aortic smooth muscle cells by
Atherosclerosis. 2009 Mar;203(1):97-104
▪ Mariani S, Basciani S, Giona F, Brama M, Gnessi L: Low bone density, slowed growth rate, gynecomastia and decreased inhibin-B/FSH ratio in a boy treated
Lancet. 2008 Jul 12;372(9633):111-2
▪ Basciani S, De Luca G, Dolci S, Brama M, Arizzi M, Mariani S, Rosano G, Spera G and Gnessi L: PDGFR-ß regulates proliferation and migration of
Endocrinology. 2008 Dec;149(12):6226-35
▪ Rossi FM, Castel i A, Bianco MJ, Bertone C, Brama M, Santiemma V: Ghrelin induces proliferation in human aortic endothelial cel s via ERK1/2 and PI3K/Akt
Peptides. 2008 Nov;29(11):2046-51.
▪ Migliaccio S, Barbaro G, Fornari R, Di Lorenzo G, Cel i M, Lubrano C, Falcone S, Fabbrini E, Greco E, Zambrano A, Brama M, Prossomariti G, Marzano S,
Marini M, Conti F, D'Eufemia P, Spera G: Impairment of diastolic function in adult patients affected by osteogenesis imperfecta clinically asymptomatic for cardiac disease: Casuality or causality Int J Cardiol. 2008 Jan 17.
▪ Migliaccio S, Brama M, Fornari R, Greco EA, Spera G and Malavolta N: Gluococorticoid-induced osteoporosis: an osteoblastic disease.
Aging Clinical and Experimental Research. 2007 Vol 19, suppl.3.
▪ Migliaccio S, Brama M, Spera G: The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on
Clin Interv Aging. 2007;2(1):55-64.
Brama M, Rhodes N, Hunt J, Ricci A, Teghil R, Migliaccio S, Rocca CD, Leccisotti S, Lioi A, Scandurra M, De Maria G, Ferro D, Pu F, Panzini G, Politi L,
Scandurra R: Effect of titanium carbide coating on the osseointegration response in vitro and in vivo. Biomaterials. 2007 Feb;28(4):595-608.
Brama M, Basciani S, Mariani S, Migliaccio S, Arizzi M, Rosano G, Spera G and Gnessi L: Osteoblast conditioned medium promotes proliferation and
sensitizes breast cancer cel s to imatinib treatment. Endocr Relat Cancer. 2007 Mar;14(1):61-72. ▪ Brama M, Gnessi L, Cherubini S, Cerul i N, Politi L, Spera G, Mariani S, Basciani S, d’Abusco AS, Scandurra R and Migliaccio S: Cadmium induces
mitogenic signaling in breast cancer cel by an ERα-dependent mechanism. Molecular and Cellular Endocrinology. 2006 Nov (22): ▪ Basciani S, Brama M, Mariani S, De Luca G, Arizzi M, Vesci L, Pisano C, Dolci S, Spera G, Gnessi L.: Imatinib mesylate inhibits Leydig cell tumor growth:
evidence for in vitro and in vivo activity. Cancer Res. 2005 Mar 1;65(5):1897-903.
Brama M, Migliaccio S: HRT e prevenzione osteoporotica: dalla biologia all’applicazione clinica, il ruolo degli estrogeni nella modulazione del tessuto osseo.
Menopause surveil ance giugno 2005.
▪ Gianni W, Ricci A, Gazzaniga P, Brama M, Pietropaolo M, Votano S, Patane F, Agliano AM, Spera G, Marigliano V, Ammendola S, Agnusdei D, Migliaccio S,
Scandurra R.: Raloxifene modulates interleukin-6 and tumor necrosis factor-alpha synthesis in vivo: results from a pilot clinical study. J Clin Endocrinol Metab. 2004 Dec;89(12):6097-9.
▪ Longo M, Brama M, Marino M, Bernardini S, Korach KS, Wetsel WC, Scandurra R, Faraggiana T, Spera G, Baron R, Teti A, Migliaccio S.: Interaction of
estrogen receptor alpha with protein kinase C alpha and c-Src in osteoblasts during differentiation. Bone. 2004 Jan;34(1):100-11.
▪ Basciani S, Mariani S, Arizzi M, Brama M, Ricci A, Betsholtz C, Bondjers C, Ricci G, Catizone A, Galdieri M, Spera G, Gnessi L.: Expression of platelet-
derived growth factor (PDGF) in the epididymis and analysis of the epididymal development in PDGF-A, PDGF-B, and PDGF receptor beta deficient Unione europea, 2002-2012 | http://europass.cedefop.europa.eu Biol Reprod. 2004 Jan;70(1):168-77.
Brama M, Scotto D’Abusco A, Migliaccio S: Osteoporosi da glucocorticoidi: malattia dell’osteoblasta.
Archivi di Ortopedia e Reumatologia vol. 115 n°4, 2004.
▪ Taranta A, Brama M, Teti A, De luca V, Scandurra R, Spera G, Agnusdei D, Termine JD, Migliaccio S.: The selective estrogen receptor modulator raloxifene
regulates osteoclast and osteoblast activity in vitro. Bone. 2002 Feb;30(2):368-76.
▪ Perez M, Migliaccio S, Taranta A, Festuccia C, Orru L, Brama M, Bologna M, Faraggiana T, Baron R, Teti A.: Melanoma cells stimulate osteoclastogenesis,
c-Src expression and osteoblast cytokines. Eur J Cancer. 2001 Mar;37(5):629-40. ▪ Mancini M, Cedrone M, Diverio D, Emanuel B, Stul M, Vranckx H, Brama M, De Cuia MR, Nanni M, Fazi F, Mecucci C, Alimena G, Hagemeijer A.: Use of dual-color interphase FISH for the detection of inv(16) in acute myeloid leukemia at diagnosis, relapse and during fol ow-up: a study of 23 patients. Leukemia. 2000 Mar;14(3):364-8.
▪ Clark R, Byatt SA, Bennett CF, Brama M, Martineau M, Moorman AV, Roberts K, Secker-Walker LM, Richards S, Eden OB, Goldstone AH, Harrison CJ.:
Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia. Unione europea, 2002-2012 | http://europass.cedefop.europa.eu

Source: http://www.sosiformazione.it/public/file/cv/BRAMA_CV.pdf

Microsoft word - trial 07 marking criteria.doc

Q.20 Criteria Correctly describes the work of Watson, Crick, Franklin and Wilkins, explains the effect of communication and collaboration, and evaluates the statement Correctly describes the work of Watson, Crick, Franklin and Wilkins, and explains the effect of communication and collaboration, OR explains and evaluates the effect of communication and collaboration Correctly describes some

Profume gas fumigant sds

SAFETY DATA SHEET Emergency Phone: 1800-033-882 (24 hrs) +61 3 9663 2130 (24 hrs) Dow AgroSciences Australia Ltd. Frenchs Forest NSW 2086 PROFUMETM GAS FUMIGANT 1. PRODUCT AND COMPANY IDENTIFICATION: PRODUCT: ProFumeTM Gas Fumigant In case of accident or if you feel unwell, seek medical advice immediately (show the label PURPOSE: Fumigant for insect control.

Copyright © 2010-2014 Medical Pdf Finder